Track record · closed signal

UnitedHealth Group Incorporated (UNH) — closed signal from December 3, 2025

Partial Published before the outcome was known, scored automatically when the window closed on March 3, 2026.

Predicted vs. what happened

UNH price · publication thesis → realized outcomesplit-adjusted
$324.75 Published $367.74 Target $289.21 Window close $357.87 Peak
$315.74 – $330.54Entry zone — fair-value band
$324.75Published — price the day we called it
$367.74Target — the price the thesis aimed for
$357.87Peak — highest point inside the window, not a realized return
$289.21Window close — end-of-window price, context only

What happened

Partial

Reached 73% of the predicted growth at its peak, without hitting the target.

Peak price
$357.87
peak on January 23, 2026 — not a realized return
Peak gain
+10.2%
peak, from the publication price
Window close
$289.21
end-of-window price, context only
Days to target
Window
December 3, 2025 – March 3, 2026

The thesis — published December 3, 2025

Predicted growth
+14%
over the measurement window
Target price
$367.74
the price the thesis aimed for
Entry zone
$315.74 – $330.54
the fair-value band we waited for
Price at publication
$324.75
published December 3, 2025
Confidence
70%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

UnitedHealth looks like a high-quality company trading at a discount after sector pressure. Recent price signals have turned more positive and momentum is recovering, suggesting a possible base. Analysts note the stock trades at a mid-teens earnings multiple and a new WeeklyPay ETF shows ongoing demand, which could support a gradual rebound despite policy risk.

Primary drivers

  • Recent positive price signals and a stabilizing recent average price hint at recovery.
  • Shares trade at a mid-teens earnings multiple, making valuation less stretched.
  • A new WeeklyPay ETF shows continued investor interest in the stock.
  • Wide mix of health benefits and services supports steady long-term earnings.

How it played out

UNH: target missed after a partial rebound

Lyra published UNH at 324.75 on 2025-12-03 with expected growth of 14%. The thesis pointed to recent positive price signals, a stabilizing recent average price, a mid-teens earnings multiple, a new WeeklyPay ETF, and a wide mix of health benefits and services. It expected a gradual rebound despite policy risk.

Inside the window, UNH rose to 357.87 on 2026-01-23, a peak gain of 10.2%. That stayed below the 367.74 target, so the target was never reached. By 2026-03-03, the stock ended at 289.21. The thesis partly played out, then failed to hold.

What happened during the window

On Jan. 27, 2026, MarketWatch reported that UnitedHealth issued a 2026 revenue outlook for a decline and reported fourth-quarter results. The same article reported that the stock closed lower that day.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.